EAM Investors’s Alpine Immune Sciences Inc ALPN Stock Holding History

EAM Investors’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-74,899	Closed	-$2.97M	–	357
2024 Q1	$2.97M	Sell	74,899 -87,786	-54%	-$2.59M	0.46%	120
2023 Q4	$3.1M	Buy	+162,685	New	+$2.26M	0.55%	110
2021 Q1	–	Sell	-63,261	Closed	-$797K	–	463
2020 Q4	$797K	Buy	+63,261	New	+$621K	0.13%	285

EAM Investors's ALPN Position: Q2 2024 in Review

EAM Investors sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 74,899 shares — an estimated $2.97M sold.

EAM Investors first reported a position in ALPN in Q4 2020 and held it in 3 quarters. The position peaked at $3.1M in Q4 2023. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

EAM Investors reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
EAM Investors sold 74,899 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $2.97M.
EAM Investors first reported a position in Alpine Immune Sciences Inc in Q4 2020 and held it in 3 quarters.
EAM Investors's Alpine Immune Sciences Inc position peaked at $3.1M in Q4 2023.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on EAM Investors's 13F filing for Q2 2024, filed 12 Aug 2024.